Fingerprint
Dive into the research topics of 'Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: Pooled results through week 52 of two phase III, randomised, placebo-controlled studies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically